News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
629,347 Results
Type
Article (39863)
Company Profile (158)
Press Release (589326)
Section
Business (175151)
Career Advice (2790)
Deals (34972)
Drug Delivery (94)
Drug Development (73276)
Employer Resources (158)
FDA (15726)
Job Trends (14799)
News (306468)
Policy (29716)
Tag
Academia (2702)
Alliances (44012)
Alzheimer's disease (1355)
Approvals (15715)
Artificial intelligence (232)
Bankruptcy (296)
Best Places to Work (12172)
Breast cancer (233)
Cancer (1765)
Cardiovascular disease (135)
Career advice (2313)
CAR-T (132)
Cell therapy (393)
Clinical research (59247)
Collaboration (708)
Compensation (380)
COVID-19 (2492)
C-suite (181)
Data (1717)
Diabetes (215)
Diagnostics (6586)
Earnings (68108)
Employer resources (139)
Events (101540)
Executive appointments (609)
FDA (16690)
Funding (629)
Gene therapy (265)
GLP-1 (614)
Government (4098)
Healthcare (19942)
Infectious disease (2608)
Inflammatory bowel disease (132)
Interviews (549)
IPO (16261)
Job creations (3087)
Job search strategy (1919)
Layoffs (429)
Legal (6711)
Lung cancer (247)
Manufacturing (249)
Medical device (13990)
Medtech (13995)
Mergers & acquisitions (19199)
Metabolic disorders (527)
Neuroscience (1791)
NextGen: Class of 2025 (6839)
Non-profit (4855)
Northern California (2213)
Obesity (274)
Opinion (225)
Patents (176)
People (51841)
Phase I (18440)
Phase II (26258)
Phase III (19648)
Pipeline (773)
Postmarket research (2083)
Preclinical (7497)
Radiopharmaceuticals (257)
Rare diseases (344)
Real estate (5045)
Regulatory (20649)
Research institute (2466)
Resumes & cover letters (455)
Southern California (1912)
Startups (3195)
United States (19572)
Vaccines (584)
Weight loss (176)
Date
Today (67)
Last 7 days (921)
Last 30 days (2951)
Last 365 days (35763)
2025 (5769)
2024 (36488)
2023 (41508)
2022 (52610)
2021 (57309)
2020 (55873)
2019 (49126)
2018 (37035)
2017 (32624)
2016 (30983)
2015 (36163)
2014 (25447)
2013 (20107)
2012 (21567)
2011 (22414)
2010 (19620)
Location
Africa (791)
Arizona (149)
Asia (37102)
Australia (6546)
California (5028)
Canada (1759)
China (409)
Colorado (229)
Connecticut (246)
Europe (85439)
Florida (748)
Georgia (181)
Illinois (473)
Indiana (279)
Japan (127)
Maryland (761)
Massachusetts (3921)
Michigan (220)
Minnesota (350)
New Jersey (1424)
New York (1433)
North Carolina (917)
Northern California (2213)
Ohio (180)
Pennsylvania (1140)
South America (1130)
Southern California (1912)
Texas (733)
Utah (162)
Washington State (487)
629,347 Results for "viatris acquired by meda ab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Relmada Therapeutics Acquires Potential Therapy for Tourette Syndrome from Asarina Pharma AB
February 6, 2025
·
7 min read
Press Releases
Idorsia and Viatris update their collaboration for selatogrel and cenerimod
February 26, 2025
·
4 min read
Patents
Novo, Viatris Settle Ozempic Patent Row
Alongside the settlement, Novo and Viatris have asked the U.S. Patent and Trademark Office to terminate its review of the validity of the Danish drugmaker’s semaglutide patents.
October 8, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Nxera Pharma Assigns Japan and APAC (ex-China) Rights to Cenerimod for Autoimmune Diseases to Viatris
February 27, 2025
·
5 min read
Deals
Vitrolife AB (publ) acquires eFertility
Vitrolife AB signed an agreement to acquire 100% of the shares in eFertility. This acquisition is a key element of the Vitrolife Group’s strategy to bring increased standardisation and digitalisation to IVF clinics around the world.
May 2, 2024
·
2 min read
Press Releases
Viatris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Financial Guidance
February 27, 2025
·
46 min read
Deals
Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company
Asahi Kasei Corp. announces that it will offer the shareholders of Calliditas Therapeutics AB to acquire the shares of the pharmaceutical company Calliditas for the purpose of making Calliditas a wholly-owned subsidiary of Asahi Kasei through a voluntary tender offer for Calliditas.
May 28, 2024
·
7 min read
Press Releases
Viatris to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
February 3, 2025
·
1 min read
Press Releases
Viatris to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 7, 2025
·
1 min read
Press Releases
Viatris Announces Third Quarter 2024 Dividend
November 5, 2024
·
4 min read
1 of 62,935
Next
